Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    12957457 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Prospective, Multicenter, Open Label and Single-arm Study of Darbepoetin Alfa for Anemia in Myelodisplastic Syndrome Patients.
Condition: Myelodysplastic Syndrome
Intervention: Drug: Darbepoetin alfa
2 Completed Dose-finding Study of Novel Erythropoiesis Stimulating Protein (NESP) for the Treatment of Anaemia in Subjects With Solid Tumours Receiving Multicycle Chemotherapy
Conditions: Anemia;   Solid Tumors
Interventions: Drug: Placebo;   Drug: Novel Erythropoiesis Stimulating Protein (NESP) (darbepoetin alfa)

Indicates status has not been verified in more than two years